about
Thymectomy for non-thymomatous myasthenia gravisMedical and surgical treatment for ocular myastheniaEnteral tube feeding for amyotrophic lateral sclerosis/motor neuron diseaseSerological, pharmacological and electrophysiological tests for the diagnosis of myasthenia gravisThymectomy for non-thymomatous myasthenia gravisPharmacological treatments of postural hypotensionTreatment for familial amyotrophic lateral sclerosis/motor neuron diseaseTreatment for familial amyotrophic lateral sclerosis/motor neuron diseaseMedical and surgical treatment for ocular myastheniaElectrical impedance myography as a biomarker to assess ALS progression.Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALSExome sequencing reveals VCP mutations as a cause of familial ALSA hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTDIncreased functional connectivity common to symptomatic amyotrophic lateral sclerosis and those at genetic riskInternational consensus guidance for management of myasthenia gravis: Executive summaryBetween Prophylaxis and Child Abuse: The Ethics of Neonatal Male CircumcisionA randomized controlled trial of methotrexate for patients with generalized myasthenia gravisDiagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis.Randomized Trial of Thymectomy in Myasthenia GravisTreatment of pyridostigmine-induced AV block with hyoscyamine in a patient with myasthenia gravis.Developing reference data for nerve conduction studies: an application of quantile regression.Reference data for commonly used sensory and motor nerve conduction studies.Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis.Magnetic resonance spectroscopy of the cervical cord in amyotrophic lateral sclerosis.A C9ORF72 BAC mouse model recapitulates key epigenetic perturbations of ALS/FTDAbnormal expression of homeobox genes and transthyretin in C9ORF72 expansion carriersAn ¹⁸F-FDG PET study of cervical muscle in parkinsonian anterocollis.Mutational analysis of the VCP gene in Parkinson's disease.Enhancing translation: guidelines for standard pre-clinical experiments in mdx miceBromodomain inhibitors regulate the C9ORF72 locus in ALSHow clinical trials of myasthenia gravis can inform pre-clinical drug developmentControversies and priorities in amyotrophic lateral sclerosis.Valosin-containing protein (VCP) mutations in sporadic amyotrophic lateral sclerosis.Clinical subtypes of anterocollis in parkinsonian syndromes.ALS biomarkers for therapy development: State of the field and future directions.A systematic review of diagnostic studies in myasthenia gravis.C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells.Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians.Lost in translation: treatment trials in the SOD1 mouse and in human ALS.Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
P50
Q24197482-39115D5A-6396-450A-8912-668F4CA940DAQ24202289-8375B55E-216E-4D11-B026-1002CBD549BAQ24234807-9CCBB746-D4A1-40EC-8416-F257B07EDEC9Q24235860-A8E8DB12-38ED-4A43-AE6F-67381D9C96B9Q24240863-5501972D-C1A8-4DFF-8B19-1CF0D89CCCD3Q24241542-2D0356A7-D77D-45F7-A2CA-C356F05DE2BCQ24241570-DC276428-3B5C-4267-A5D6-C06694EB2AD1Q24245711-DE7E2D74-986C-4872-B047-02A37060E05FQ24246392-1D65DD9B-30A1-4549-ADCD-5F7174723896Q24615680-2562DF96-B360-473C-89ED-8428E885DD56Q24629495-ECC023CC-8840-406D-82DE-2AE0DFD631DDQ24631513-308C50D0-AAA3-40F1-A60C-4A8EBF21CC2DQ24634583-F3166307-FCF0-4BC1-8AD3-3855E44D1B50Q24658568-CC3508C9-FC97-4219-A492-EB585714F034Q26746047-A537061C-8B97-4B19-88A8-AF0AF350F57DQ28315365-5E2CC11C-30E2-4800-B2A0-083F8130CB44Q30276605-28D97855-9373-4C8E-A1D1-F499FD6595E4Q30660585-CE036831-A9E0-4B73-8E66-27DCB68B1690Q30833195-010408E1-E87B-4201-A985-2D3E66A77C95Q33155451-644E8FC3-F7DE-4E1B-9A10-CBC7A2419C1AQ33510379-3E5E42EB-5D24-4314-B737-4F7353640000Q33510380-A3C0DC7A-CD4C-4721-BED4-F9D8B53F099EQ33687938-A5478B55-A98B-40CC-A06C-17CD3F5003D4Q33766375-4A558A14-42CC-4FE0-962B-BF844822C586Q33791480-2863AB67-6CC1-49BE-AD72-FBF7831A8744Q33821516-AE256615-5687-46D5-A23E-FEBD9FA0AB8AQ35009099-EDA5D766-41AE-4D8C-BA0D-0ED61D875CEDQ35566788-A760D7F3-AEDA-49ED-BAF9-AC07ACBFB406Q35583176-4F7B1F6E-9E3B-4BE2-8DE8-9571D47198EFQ35670978-8C5E2A2E-8111-4541-95DC-9B67996896D7Q35738870-851992FA-9EA7-4134-B3AC-7C41007010FDQ36045826-28AD5315-A3DD-4741-9C5B-7E8B5FF37A01Q36080866-D1965F0A-7ED2-4631-8988-F3D9F0AF0B6CQ36391290-7F80AEC1-B4BB-4EE4-B485-13B786E6748BQ36479616-FEDF3B9F-3D44-4A94-A800-3B04E65B75C3Q36515682-2291FE93-FF89-41C2-86E3-A4E028EEF381Q36600364-8F803649-096A-46A2-B148-1ACEE7EDFF52Q36652330-B0B19EEB-7C3E-4B24-A849-97A2CD7DA58EQ36735871-C61DFDC3-D4F7-494D-9276-55D49D2CAB04Q36789988-A60F8966-BCCA-43C8-85BA-6C88BBB57128
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael Benatar
@ast
Michael Benatar
@en
Michael Benatar
@es
Michael Benatar
@nl
Michael Benatar
@sl
type
label
Michael Benatar
@ast
Michael Benatar
@en
Michael Benatar
@es
Michael Benatar
@nl
Michael Benatar
@sl
prefLabel
Michael Benatar
@ast
Michael Benatar
@en
Michael Benatar
@es
Michael Benatar
@nl
Michael Benatar
@sl